Design, expression, and characterization of a synthetic human cannabinoid receptor and cannabinoid receptor/G-protein fusion protein

被引:20
作者
Farrens, DL [1 ]
Dunham, TD [1 ]
Fay, JF [1 ]
Dews, IC [1 ]
Caldwell, J [1 ]
Nauert, B [1 ]
机构
[1] Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA
来源
JOURNAL OF PEPTIDE RESEARCH | 2002年 / 60卷 / 06期
关键词
CB1; cannabinoid receptor; synthetic gene; fusion protein; GPCR; G-protein;
D O I
10.1034/j.1399-3011.2002.21066.x
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We report here the synthesis and characterization of two gene constructs designed to facilitate structure/function studies of the human neuronal cannabinoid receptor, CB1. The first gene, which we call shCB1, is a synthetic gene containing unique restriction sites spaced roughly 50-100 bases apart to facilitate rapid mutagenesis and cloning. A nine amino acid epitope tag (from the rhodopsin C-terminus) is also present in the shCB1 C-terminal tail to enable detection and purification using the monoclonal antibody 1D4. We find that that the shCB1 gene can be transiently expressed in COS cells with yield of similar to10-15 mug receptor per 15 cm plate and is wild type like in its ability to bind cannabinoid ligands. Our confocal microscopy studies indicate shCB1 targets to the membrane of HEK293 cells and is internalized in response to agonist. To facilitate functional studies, we also made a chimera in which the C-terminus of shCB1 was fused with the N-terminus of a G-protein alpha subunit, God. The shCB1/Galphai chimera shows agonist stimulated GTPgammaS binding, and thus provides a simplified way to measure agonist induced CB1 activation. Taken together, the shCB1 and shCB1/Gad gene constructs provide useful tools for biochemical and biophysical examinations of CB1 structure, activation and attenuation.
引用
收藏
页码:336 / 347
页数:12
相关论文
共 41 条
[1]  
André S, 1998, J VIROL, V72, P1497
[2]   A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1 - Evidence for a new model of receptor/ligand interactions [J].
Bouaboula, M ;
Perrachon, S ;
Milligan, L ;
Canat, X ;
RinaldiCarmona, M ;
Portier, M ;
Barth, F ;
Calandra, B ;
Pecceu, F ;
Lupker, J ;
Maffrand, JP ;
LeFur, G ;
Casellas, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) :22330-22339
[3]   CONSTRUCTION OF A 3D MODEL OF THE CANNABINOID CB1 RECEPTOR - DETERMINATION OF HELIX ENDS AND HELIX ORIENTATION [J].
BRAMBLETT, RD ;
PANU, AM ;
BALLESTEROS, JA ;
REGGIO, PH .
LIFE SCIENCES, 1995, 56 (23-24) :1971-1982
[4]  
CARRUTHERS CJL, 1994, J BIOL CHEM, V269, P29321
[5]  
CHERRY M, 1992, CODON USAGE FREQUENC
[6]   CALCULATING RECEPTOR NUMBER FROM BINDING EXPERIMENTS USING SAME COMPOUND AS RADIOLIGAND AND COMPETITOR [J].
DEBLASI, A ;
OREILLY, K ;
MOTULSKY, HJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (06) :227-229
[7]   Magic angle spinning NMR of the protonated retinylidene Schiff base nitrogen in rhodopsin:: Expression of 15N-lysine- and 13C-glycine-labeled opsin in a stable cell line [J].
Eilers, M ;
Reeves, PJ ;
Ying, WW ;
Khorana, HG ;
Smith, SO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) :487-492
[8]  
Eilers M, 2002, METHOD ENZYMOL, V343, P212
[9]   TOTAL SYNTHESIS OF A GENE FOR BOVINE RHODOPSIN [J].
FERRETTI, L ;
KARNIK, SS ;
KHORANA, HG ;
NASSAL, M ;
OPRIAN, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (03) :599-603
[10]   NUCLEOTIDE-SEQUENCE OF A HUMAN CANNABINOID RECEPTOR CDNA [J].
GERARD, C ;
MOLLEREAU, C ;
VASSART, G ;
PARMENTIER, M .
NUCLEIC ACIDS RESEARCH, 1990, 18 (23) :7142-7142